{
    "title": "China's Fosun to seek approval for BioNTech's COVID-19 second vaccine, ends trials on first",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8912915/Chinas-Fosun-seek-approval-BioNTechs-COVID-19-second-vaccine-ends-trials-first.html",
    "date": "2020-11-04",
    "keywords": [
        "china",
        "candidate",
        "fosun",
        "hui",
        "bnt162b2",
        "vaccine",
        "use",
        "safety",
        "month",
        "bnt162b1",
        "bridge",
        "trial",
        "partner",
        "group",
        "earlystage",
        "executive",
        "approval",
        "biontechs",
        "finalstage",
        "officer",
        "aimin",
        "interview",
        "biontech",
        "inc",
        "review",
        "europe",
        "emergency",
        "authorisation",
        "window",
        "phase",
        "day",
        "study",
        "populace",
        "efficacy",
        "administration",
        "latestage",
        "time",
        "clearance",
        "mrna",
        "technology",
        "hong",
        "kong",
        "macau",
        "taiwan",
        "return",
        "licensing",
        "stake",
        "firm",
        "reporting",
        "roxanne",
        "liu",
        "suzhou",
        "monroe",
        "editing",
        "miyoung",
        "raju",
        "gopalakrishnan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}